General description
INN
Deferasirox
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2023
(TRS
1049)
for
Other specified sickle cell disorders or other haemoglobinopathies
Added in 2023
(TRS
1049)
for
Thalassaemias
Changed in 2023
(TRS
1049)
for
Thalassaemias
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Other medicines for haemoglobinopathies
- Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg
- Oral > Solid > tablet: 90 mg; 180 mg; 360 mg